NASDAQ · Financial Statements
Athira Pharma, Inc. (ATHA) Financial Statements
$6.75
NASDAQ: ATHA
Market Cap $26.62M
Overview Financials Dividend Athira Pharma, Inc. most recently reported annual revenue of $0, net profit of $-106.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-64.0M $-104.0M $-125.0M $-101.0M $-102.0M Net Profit $-55.0M $-96.0M $-118.0M $-97.0M $-106.0M EPS $-14.90 $-25.30 $-30.90 $-25.20 $-24.70 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $332.0M $258.0M $160.0M $59.0M $92.0M Total Liabilities $11.0M $23.0M $30.0M $14.0M $64.0M Cash $111.0M $96.0M $91.0M $48.0M $69.0M Borrowings $2.0M $2.0M $2.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-43.0M $-72.0M $-101.0M $-97.0M $-46.0M Investing Cash Flow $-6.0M $57.0M $95.0M $55.0M $-16.0M Financing Cash Flow $0 $0 $0 $0 $82.0M Net Cash Flow $50.0M $-15.0M $-5.0M $-42.0M $21.0M Free Cash Flow $-45.0M $-74.0M $-101.0M $-97.0M $-46.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.03 FCF Yield -155.93% Quick Ratio 10.38 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock